Skip to content

Autonomic Effects of T4 Mobilization in Asymptomatic Subjects

Autonomic Effects of T4 Mobilization in Asymptomatic Subjects: Randomized Clinical Trial

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02164123
Enrollment
86
Registered
2014-06-16
Start date
2014-07-31
Completion date
2014-12-31
Last updated
2015-03-09

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Other Disorders of the Autonomic Nervous System, Vertebra; Degeneration

Keywords

Autonomic effects, spinal mobilization, clinical trial

Brief summary

The purpose of this study is to determine whether passive accessory intervertebral mobilization applied to the fourth thoracic vertebra produces autonomic effects.

Detailed description

Asymptomatic subjects will be recruited to this study. Pressure pain threshold, heart rate, heart rate variability and skin conductance will be measured before, immediately after and fifteen minutes after the intervention. Subjects will be randomized into three groups: Passive accessory intervertebral mobilization one, passive accessory intervertebral mobilization two and placebo group. The researcher that will do the intervention will be blinded to the outcomes measures, and the researcher that will do the measurements will be blind to the intervention.

Interventions

Experimental group

OTHERSpinal Mobilization II

Active comparator group

OTHERPlacebo

Placebo group

Sponsors

Federal University of Health Science of Porto Alegre
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
DOUBLE (Investigator, Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
18 Years to 40 Years
Healthy volunteers
Yes

Inclusion criteria

* Asymptomatic subjects * Aged between 18 - 40 years old * Portuguese readers and writers

Exclusion criteria

* History of lesion or surgery to the spine

Design outcomes

Primary

MeasureTime frameDescription
Skin conductanceChange from Baseline imediately after, and 15 minutes after the interventionSkin conductance will be measured with Biopac MP150, the electrodes will be attached to the third and fourth fingers bilaterally. This measurement will be made during all the procedure, before, during and until 15 minutes after the intervention.

Secondary

MeasureTime frameDescription
Pressure pain thresholdChange from Baseline imediately after, and 15 minutes after the interventionPressure pain threshold will be measured with a digital algometer (Model FDX 10; Wagner Instruments, Greenwich, CT). This measurement will be made on the spinous process of C5 and T4, on the first dorsal interossei, and on the anterior tibial tuberosity bilaterally.

Other

MeasureTime frameDescription
Heart rate variabilityChange from Baseline imediately after the interventionHeart rate variability will be measured with a Polar Advantage Interface (Polar Electro Oy, Kempele, Finland). The belt will be positioned centrally, directly below the xiphisternum. Heart rate data acquisition will me made for 5 minutes at baseline and for 5 minutes immediately after the intervention.

Countries

Brazil

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026